| March of Dimes Grant
Supports Craniofacial Research
Yang
Chai's study of embryonic cells that shape craniofacial
structures gained new support from a three-year, $225,000 March of
Dimes Birth Defects Foundation grant "This funding source has
infrequently supported craniofacial research so receiving this grant
is a real accomplishment," said Charles Shuler, director of the
school's Center for Craniofacial Molecular Biology.
How embryonic cells develop and
multiply as they travel from the cranial neural crest (CNC) of a
developing embryo is critical. It can determine whether a newborn
has normal craniofacial features or is one who suffers from cleft
lip and/or palate. According to figures from the March of Dimes
Perinatal Data Center, 2000, an estimated one out of every 930 U.S.
children are born each year with oral clefts-one of the most common
birth defects in the United States.
"Growth and transcriptional
factors are critical regulators for the fate of cranial neural crest
cells," explained Chai. TGF-beta, a transforming growth factor,
and Msx1, a transcription factor, are the focus of attention for
Chai and colleagues. It is known that TGF-beta can negatively affect
the expression of Msx1, a factor critical for proliferation and
differentiation of cells into phenotypes, such as teeth, cartilage
and bone. Just what this means for the future of CNC cells is what
Chai hopes to learn.
He and colleagues are looking at the
signaling that occurs through a string of molecules between
TGF-beta2 and Msx1. They want to see if the molecules that carry the
signal are specific for regulating tooth development, and, if so, to
determine the significance and consequences.
"Ultimately, this study will
contribute to our understanding how the signaling pathway between
TGF-beta and Msx1 regulates the fate of CNC during normal
craniofacial development and how pathway disruption can lead to
craniofacial malformations," Chai said. His colleagues in this
study include Jun Han, a USC graduate student in craniofacial
molecular biology, and Yoshihiro Ito, research associate. |